Comparison of Clinical Cure Rates of Doxycycline and Levofloxacin in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Abstract
Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a major cause of morbidity and health-care utilisation. Comparative evidence for commonly used oral antibiotics in ambulatory settings remains limited. This study assessed the early clinical efficacy of doxycycline versus levofloxacin in outpatient AECOPD. Methods: This randomized controlled trial was conducted in the Pulmonology Department of Lahore General Hospital, Lahore, over a five-month period (January–May 2025) after obtaining Institutional Review Board approval (2025/ERC/20) and completing trial registration (NCT06915688). Adults aged 40–75 years with spirometry-confirmed COPD and an acute exacerbation were enrolled and randomly assigned to receive oral doxycycline 100 mg twice daily or levofloxacin 500 mg once daily for five days. Clinical cure, requiring fulfilment of at least four of six predefined criteria, was evaluated two days after treatment. Baseline and follow-up clinical and laboratory parameters were analysed using appropriate statistical tests. Results: A total of 131 participants completed follow-up (62 doxycycline, 69 levofloxacin). Overall clinical cure occurred in 85.5% of the levofloxacin group versus 67.7% of the doxycycline group (χ²=5.837, p=0.016). Restoration of oxygen saturation to 88–92% was significantly more frequent with levofloxacin (98.6% vs 87.1%; p=0.010), and follow-up SpO₂ was modestly higher (89.94±1.30% vs 89.42±1.27%; p=0.022). Reductions in…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.